MacNeil S D, Liu K, Shariff S Z, Thind A, Winquist E, Yoo J, Nichols A, Fung K, Hall S, Garg A X
Department of Otolaryngology-Head and Neck Surgery, Western University, London, ON. ; Institute for Clinical and Evaluative Sciences, Toronto, ON. ; Department of Oncology, Western University, London, ON.
Institute for Clinical and Evaluative Sciences, Toronto, ON.
Curr Oncol. 2015 Apr;22(2):e85-99. doi: 10.3747/co.22.2361.
Recent reports suggest a decline over time in the survival of patients newly diagnosed with laryngeal cancer in spite of developments in treatment practices. Our study set out to determine whether the survival of patients with laryngeal cancer in Ontario has changed over time.
This population-based cohort study of patients diagnosed with laryngeal cancer in the province of Ontario between 1995 and 2007 used data extracted from linked provincial administrative and registry databases. Its main outcomes were overall survival, laryngectomy-free survival, and survival ratio relative to an age- and sex-matched general population.
The 4298 patients newly diagnosed with laryngeal cancer during the period of interest were predominantly men (n = 3615, 84.1%) with glottic cancer (n = 2787, 64.8%); mean age in the group was 66 years (interquartile range: 59-74 years). Patient demographics did not significantly change over time. Overall, 5-year survival was 57.4%; laryngectomy-free survival was 45.4%. Comparing patients from three eras (1995-1998, 1999-2003, 2004-2007) and adjusting for age, sex, and comorbidity status, we observed no differences in overall survival or laryngectomy-free survival over time. The 5-year relative survival ratio for patients with laryngeal cancer compared with an age- and sex-matched group from the general population was 81.1% for glottic cancer and 44.5% for supraglottic cancer.
In patients with a new diagnosis of laryngeal cancer, overall and laryngectomy-free survival have remained unchanged since the mid-1990s. New methods to improve survival and the rate of laryngeal preservation in this patient population are needed.
近期报告显示,尽管治疗方法有所进展,但新诊断为喉癌的患者生存率随时间呈下降趋势。我们的研究旨在确定安大略省喉癌患者的生存率是否随时间发生了变化。
这项基于人群的队列研究,对1995年至2007年期间在安大略省被诊断为喉癌的患者进行了研究,使用了从省级行政和登记数据库中提取的关联数据。其主要结局指标为总生存率、无喉切除术生存率以及相对于年龄和性别匹配的普通人群的生存比率。
在研究期间新诊断为喉癌的4298例患者中,男性居多(n = 3615,84.1%),声门癌患者居多(n = 2787,64.8%);该组患者的平均年龄为66岁(四分位间距:59 - 74岁)。患者人口统计学特征随时间未发生显著变化。总体而言,5年生存率为57.4%;无喉切除术生存率为45.4%。比较三个时期(1995 - 1998年、1999 - 2003年、2004 - 2007年)的患者,并对年龄、性别和合并症状态进行调整后,我们观察到总生存率或无喉切除术生存率随时间并无差异。与年龄和性别匹配的普通人群组相比,声门癌患者的5年相对生存率为81.1%,声门上癌患者为44.5%。
自20世纪90年代中期以来,新诊断为喉癌的患者的总生存率和无喉切除术生存率保持不变。需要新的方法来提高该患者群体的生存率和喉保留率。